Precision and targeted therapy in cardiac surgery

With more than 300,000 cases being performed annually in the United States alone, a coronary artery bypass grafting (CABG) is the preferred method for revascularization for most patients that are suffering from a multivessel coronary artery disease or diabetes (1). Secondary to its long term patency and survival benefits, if suitable and surgically feasible, the left internal mammary artery remains the conduit of choice for the bypassing of the left anterior descending coronary artery (2).